Panic Disorder
A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.
Drugs by status
Approved for this indication (6)
Phase 4 trials (12)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (33)
- Bristol-Myers Squibb
- AstraZeneca
- Purdue Pharmaceuticals
- GlaxoSmithKline
- Hamilton Health Sciences Corporation
- National Institute of Mental Health (NIMH)
- University of Pennsylvania
- Maastricht University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Harvard University
- Georgetown University
- University of Washington
- Hoosier Cancer Research Network
- Indiana University
- Inje University
- McMaster University
- Siyan Clinical Corporation
- University of South Florida
- Creighton University
- University of Buenos Aires
- University of California, Los Angeles
- University of California, San Diego
- University of Cincinnati
- Federal University of Rio de Janeiro
- Janssen Pharmaceutica NV
- St Lucas and Andreas Hospital, Amsterdam
- University of Goettingen
- RAND Corporation
- Department of Veteran Affairs
- Lundbeck
- +3 more
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (8)